Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 3695 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 3801 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 3893 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 3894 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 4289 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 4335 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 4824 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5030 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5096 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5348 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5355 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5732 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5765 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 6742 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 7022 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 7269 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 9089 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 10005 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 1498 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 1623 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 2479 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 3095 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Healthy control | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Severe disease |